Browse EV MemProt Atlas
Frequency:
literature support frequency.
EVMP score:

annotation confidence score.

Extremely high >= 0.85High >= 0.70Medium >= 0.55Low >= 0.40
UniProt IDProtein namesProtein classificationTransmembrane countRelated DiseasesMediation categoriesDownload
FGFR3P22607Fibroblast growth factor receptor 3 (FGFR-3) (EC 2.7.10.1) (CD antigen CD333)Cancer-related genesCD markersDisease related genesEnzymesFDA approved drug targetsHuman disease related genesPredicted intracellular proteinsPredicted membrane proteinsPredicted secreted proteinsRAS pathway related proteins1Alzheimer diseaseBladder cancerBreast cancerCoronary atherosclerosisEndometrial cancerLiver cancerMultiple myelomaMyeloproliferative neoplasmMyocardial infarctionRenal cell carcinomaRetina cancerSkeletal anomalySolid tumour/cancerUreteral cancerAdhesion and uptake mediationClinical-translation mediationFusion and delivery mediationReceptor-signaling mediation110.47
K319LQ8IZA0Dyslexia-associated protein KIAA0319-like protein (Adeno-associated virus receptor) (AAVR)Predicted intracellular proteinsPredicted membrane proteins2Other mediation100.38
MUC16Q8WXI7Mucin-16 (MUC-16) (Ovarian cancer-related tumor marker CA125) (CA-125) (Ovarian carcinoma antigen CA125)Plasma proteinsPredicted membrane proteinsPredicted secreted proteins1Fallopian tube cancerMalignant mesenchymal neoplasmMature B-cell lymphomaOvarian cancerPeritoneal cancerClinical-translation mediationFusion and delivery mediationImmune mediationMetabolism mediation100.38
SEM7AO75326Semaphorin-7A (CDw108) (JMH blood group antigen) (John-Milton-Hargen human blood group Ag) (Semaphorin-K1) (Sema K1) (Semaphorin-L) (Sema L) (CD antigen CD108)Blood group antigen proteinsCD markersDisease related genesHuman disease related genesPlasma proteinsPredicted membrane proteinsFusion and delivery mediationImmune mediationReceptor-signaling mediation100.38
BST2Q10589Bone marrow stromal antigen 2 (BST-2) (HM1.24 antigen) (Tetherin) (CD antigen CD317)CD markersPlasma proteinsPredicted membrane proteinsTransporters1Clinical-translation mediationFusion and delivery mediationImmune mediationReceptor-signaling mediation90.38
CD53P19397Leukocyte surface antigen CD53 (Cell surface glycoprotein CD53) (Tetraspanin-25) (Tspan-25) (CD antigen CD53)CD markersPredicted membrane proteinsTransporters4Fusion and delivery mediationImmune mediation90.38
CXCR1P25024C-X-C chemokine receptor type 1 (CXC-R1) (CXCR-1) (CDw128a) (High affinity interleukin-8 receptor A) (IL-8R A) (IL-8 receptor type 1) (CD antigen CD181)Cancer-related genesCD markersG-protein coupled receptorsPredicted membrane proteins7Chronic obstructive pulmonary diseaseGoutIndeterminate colitisLiver vascular disorderMedical/surgical procedure injuryMelanomaMyelodysplastic syndromePainSolid tumour/cancerTransplant rejectionUlcerative colitisAdhesion and uptake mediationClinical-translation mediationFusion and delivery mediationImmune mediationReceptor-signaling mediation90.38
SC6A6P31641Sodium- and chloride-dependent taurine transporter (Solute carrier family 6 member 6) (Taurine transporter) (TauT)Disease related genesMetabolic proteinsPotential drug targetsPredicted membrane proteinsTransporters12Clinical-translation mediationFusion and delivery mediation90.38
CEAM6P40199Cell adhesion molecule CEACAM6 (Carcinoembryonic antigen-related cell adhesion molecule 6) (CEA cell adhesion molecule 6) (Non-specific crossreacting antigen) (Normal cross-reacting antigen) (CD antigen CD66c)Cancer-related genesCD markersPredicted intracellular proteinsPredicted membrane proteinsAdhesion and uptake mediationFusion and delivery mediationImmune mediation80.38
CLN3Q13286Battenin (Batten disease protein) (Protein CLN3)Disease related genesHuman disease related genesPotential drug targetsPredicted intracellular proteinsPredicted membrane proteinsTransporters6Lysosomal diseaseAdhesion and uptake mediationClinical-translation mediationFusion and delivery mediationImmune mediationMetabolism mediationReceptor-signaling mediation80.38
CNNM3Q8NE01Metal transporter CNNM3 (Ancient conserved domain-containing protein 3) (Cyclin-M3)Predicted membrane proteinsTransporters4Metabolism mediation80.38
CR2P20023Complement receptor type 2 (Cr2) (Complement C3d receptor) (Epstein-Barr virus receptor) (EBV receptor) (CD antigen CD21)CD markersDisease related genesHuman disease related genesPlasma proteinsPredicted intracellular proteinsPredicted membrane proteins1Immune mediation80.38
PEAR1Q5VY43Platelet endothelial aggregation receptor 1 (hPEAR1) (Multiple epidermal growth factor-like domains protein 12) (Multiple EGF-like domains protein 12)Plasma proteinsPredicted intracellular proteinsPredicted membrane proteins1Immune mediationMetabolism mediationReceptor-signaling mediation80.38
ANPRBP20594Atrial natriuretic peptide receptor 2 (EC 4.6.1.2) (Atrial natriuretic peptide receptor type B) (ANP-B) (ANPR-B) (NPR-B) (Guanylate cyclase B) (GC-B)1Immune mediationReceptor-signaling mediation70.38
BASIP35613Basigin (5F7) (Collagenase stimulatory factor) (Extracellular matrix metalloproteinase inducer) (EMMPRIN) (Hepatoma-associated antigen) (HAb18G) (Leukocyte activation antigen M6) (OK blood group antigen) (Tumor cell-derived collagenase stimulatory factor) (TCSF) (CD antigen CD147)Blood group antigen proteinsCD markersPredicted intracellular proteinsPredicted membrane proteinsTransporters1Graft-versus-host diseaseLiver cancerCOVID-19Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediationImmune mediationReceptor-signaling mediation70.38
CD19P15391B-lymphocyte antigen CD19 (B-lymphocyte surface antigen B4) (Differentiation antigen CD19) (T-cell surface antigen Leu-12) (CD antigen CD19)CD markersDisease related genesFDA approved drug targetsHuman disease related genesPredicted membrane proteins1Acute myeloid leukaemiaB-cell lymphomaDiabetes mellitusDiffuse large B-cell lymphomaEncephalopathyFollicular lymphomaHodgkin lymphomaImmune system diseaseImmunoproliferative disorderLeukaemiaLupus erythematosusLymphomaMalignant haematopoietic neoplasmMature B-cell leukaemiaMature B-cell lymphomaMultiple myelomaNervous system paraneoplastic/autoimmune disorderNeuromyelitis opticaPancreatic cancerPrecursor B-lymphoblastic neoplasmRheumatoid arthritisSjogren syndromeSystemic sclerosisClinical-translation mediationFusion and delivery mediationImmune mediationMetabolism mediationReceptor-signaling mediation70.38
ROR2Q01974Tyrosine-protein kinase transmembrane receptor ROR2 (EC 2.7.10.1) (Neurotrophic tyrosine kinase, receptor-related 2)1Metastatic lymph node neoplasmRenal cell carcinomaClinical-translation mediationFusion and delivery mediationImmune mediationReceptor-signaling mediation70.38
S12A9Q9BXP2Solute carrier family 12 member 9 (Cation-chloride cotransporter 6) (hCCC6) (Cation-chloride cotransporter-interacting protein 1) (CCC-interacting protein 1) (hCIP1) (Potassium-chloride transporter 9) (WO3.3)Predicted membrane proteinsTransporters12Fusion and delivery mediation70.38
TRPC6Q9Y210Short transient receptor potential channel 6 (TrpC6) (Transient receptor protein 6) (TRP-6)Disease related genesHuman disease related genesPlasma proteinsPotential drug targetsPredicted membrane proteinsTransportersVoltage-gated ion channels6Fusion and delivery mediationImmune mediationMetabolism mediationReceptor-signaling mediation70.38
CADM3Q8N126Cell adhesion molecule 3 (Brain immunoglobulin receptor) (Immunoglobulin superfamily member 4B) (IgSF4B) (Nectin-like protein 1) (NECL-1) (Synaptic cell adhesion molecule 3) (SynCAM3) (TSLC1-like protein 1) (TSLL1)Disease related genesHuman disease related genesPredicted intracellular proteinsPredicted membrane proteins1Adhesion and uptake mediationReceptor-signaling mediation60.38
CEAM8P31997Cell adhesion molecule CEACAM8 (CD67 antigen) (Carcinoembryonic antigen CGM6) (Carcinoembryonic antigen-related cell adhesion molecule 8) (CEA cell adhesion molecule 8) (Non-specific cross-reacting antigen NCA-95) (CD antigen CD66b)CD markersPlasma proteinsPredicted intracellular proteinsAdhesion and uptake mediationFusion and delivery mediationImmune mediation60.38
CRIM1Q9NZV1Cysteine-rich motor neuron 1 protein (CRIM-1) (Cysteine-rich repeat-containing protein S52) [Cleaved into: Processed cysteine-rich motor neuron 1 protein]Predicted intracellular proteinsPredicted membrane proteinsTransporters1Other mediation60.38
ENPP3O14638Ectonucleotide pyrophosphatase/phosphodiesterase family member 3 (E-NPP 3) (NPP3) (Alkaline phosphodiesterase I) (EC 3.1.4.1) (Dinucleoside polyphosphatase) (EC 3.6.1.-) (Nucleotide diphosphatase) (Nucleotide pyrophosphatase) (NPPase) (EC 3.6.1.9) (Phosphodiesterase I beta) (PD-Ibeta) (Phosphodiesterase I/nucleotide pyrophosphatase 3) (CD antigen CD203c)CD markersEnzymesMetabolic proteinsPredicted intracellular proteinsPredicted secreted proteins1Renal cell carcinomaClinical-translation mediationFusion and delivery mediationImmune mediationMetabolism mediation60.38
EPHB3P54753Ephrin type-B receptor 3 (EC 2.7.10.1) (EPH-like tyrosine kinase 2) (EPH-like kinase 2) (Embryonic kinase 2) (EK2) (hEK2) (Tyrosine-protein kinase TYRO6)Cancer-related genesEnzymesPredicted membrane proteins1Adhesion and uptake mediationReceptor-signaling mediation60.38
FCER2P06734Low affinity immunoglobulin epsilon Fc receptor (BLAST-2) (C-type lectin domain family 4 member J) (Fc-epsilon-RII) (Immunoglobulin E-binding factor) (Lymphocyte IgE receptor) (CD antigen CD23) [Cleaved into: Low affinity immunoglobulin epsilon Fc receptor membrane-bound form; Low affinity immunoglobulin epsilon Fc receptor soluble form]Cancer-related genesCD markersPredicted intracellular proteinsPredicted membrane proteinsPredicted secreted proteins1Adhesion and uptake mediationFusion and delivery mediationImmune mediationReceptor-signaling mediation60.38